Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Most US adults with medical debt owe hospitals

A significant portion of U.S. adults have some past-due medical debt, according to a recent study from the Urban Institute, and the majority of those with debt owe non-profit hospitals.

Thumbnail

Is ultra low-dose CT a feasible option for identifying fractures?

Such scans offer significant reductions in radiation exposure, but there is concern that lower dosage might sacrifice image quality, causing readers to miss important findings. 

The SAPIEN 3 Ultra (S3U) transcatheter heart valve from Edwards Lifesciences is

Next-generation TAVR valve delivers strong outcomes, reduced PVL after one year

A team of specialists examined new outcomes data related to the SAPIEN 3 Ultra transcatheter heart valve, sharing its findings in EuroIntervention.

Medicare money payment physician

AMA pressures federal government to fix prior authorization problem plaguing radiology

About 89% of physicians surveyed believe that this payer tactic has had a negative impact on care, the association reported Monday. 

Google ups activity in 4 reaches of healthcare AI

Along with expanding research into large-language models to rival OpenAI’s ChatGPC, the search-engine king is working on AI for improving maternal care, ultrasound access and tuberculosis screening.

Thumbnail

Should radiology programs up their hands-on ultrasound training?

Many courses exist for teaching US scanning to non-radiologists, but fewer courses are available to radiologists who need to strengthen their core skills,” experts recently wrote in Academic Radiology.

Thumbnail

Sanofi to acquire Provention Bio for $2.9B

Provention Bio's TZIELD is the first and only therapy to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and pediatric patients aged 8 years and older with Stage 2 T1D. 

 

Thumbnail

New Radiology study offers key clues as to where practices should prioritize expansion plans

Individuals living in "extremely disadvantaged" ZIP codes are less likely to have access to accredited imaging facilities.